STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
2 Months Ended |
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
|
|
Mar. 17, 2021 |
Feb. 28, 2021 |
Feb. 24, 2021 |
Feb. 11, 2021 |
Jan. 25, 2021 |
Nov. 22, 2020 |
Sep. 25, 2020 |
Jul. 21, 2020 |
Jul. 06, 2020 |
Feb. 05, 2020 |
Dec. 31, 2020 |
Jul. 31, 2020 |
Apr. 30, 2020 |
Jun. 17, 2020 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
Jun. 30, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Dec. 31, 2020 |
Jul. 22, 2020 |
Jul. 17, 2020 |
Jul. 08, 2020 |
Jun. 19, 2020 |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
Cash proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 58,269,829
|
$ 6,455,992
|
|
|
|
|
|
Shares issued during conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,041,491
|
$ 183,425
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
469,576
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,337,494
|
$ 307,408
|
|
|
|
|
|
Preferred stock, designated |
|
|
|
|
|
|
|
|
|
|
20,000,000
|
|
|
|
20,000,000
|
|
20,000,000
|
|
20,000,000
|
|
20,000,000
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
$ 8.03
|
|
|
|
$ 7.37
|
|
$ 8.03
|
|
$ 7.37
|
|
$ 8.03
|
|
|
|
|
Exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 515,338
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
3,501,014
|
|
|
|
6,108,823
|
|
3,501,014
|
|
6,108,823
|
|
3,501,014
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.40%
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.70%
|
|
|
|
|
|
Advisors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,037,496
|
|
|
|
|
Merger Sub [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,337,663
|
|
|
|
|
Value of common stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,060,740
|
|
|
|
|
Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of common stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 681,725
|
|
|
|
|
|
|
Restricted Stock [Member] | Long-Term Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,087,618
|
|
|
|
|
Weighted average price restricted stock |
|
|
|
|
|
|
|
|
|
|
$ 5.27
|
|
|
|
|
|
$ 5.27
|
|
|
|
$ 5.27
|
|
|
|
|
Number of shares vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,115
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,407,012
|
|
|
|
2,836,541
|
|
|
|
|
|
|
Restricted Stock [Member] | Core IR [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock [Member] | Core IR [Member] | General and Administrative Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 42,300
|
|
|
|
|
Restricted Stock [Member] | Director [Member] | 2020 Long-Term Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of restricted stock units |
|
|
172,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price |
|
|
$ 7.66
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AYRO Seed Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 36,760
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
461,647
|
|
|
|
461,647
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.33
|
|
|
|
$ 7.33
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
5 years
|
|
|
|
|
|
|
Exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
Exercise of warrants, Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,642
|
|
|
|
|
|
|
AYRO Seed Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
448,005
|
|
|
|
448,005
|
|
|
|
|
|
|
Series I Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,636
|
|
|
|
14,636
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 69.00
|
|
|
|
$ 69.00
|
|
|
|
|
|
|
Warrants description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If at any time (i)
the volume weighted average price (“VWAP”) of the Common Stock exceeds $138.00 for not less than the mandatory exercise measuring
period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds
25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder
to exercise all or any portion of the Series I Warrants.
|
|
|
|
|
|
|
Warrant weighted average exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 138.00
|
|
|
|
$ 138.00
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,636
|
|
|
|
14,636
|
|
|
|
|
|
|
Series H-3 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,800
|
|
|
|
2,800
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 165.60
|
|
|
|
$ 165.60
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
5 years
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,800
|
|
|
|
2,800
|
|
|
|
|
|
|
Series H-4 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37,453
|
|
|
|
37,453
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15.60
|
|
|
|
$ 15.60
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37,453
|
|
|
|
37,453
|
|
|
|
|
|
|
Anti-dilution price protection price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15.60
|
|
|
|
$ 15.60
|
|
|
|
|
|
|
Series J Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52,023
|
|
|
|
52,023
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 30.00
|
|
|
|
$ 30.00
|
|
|
|
|
|
|
Warrants description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If
at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily
average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no
equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or
any portion of the Series J Warrants still unexercised for a cash exercise.
|
|
|
|
|
|
|
Warrant weighted average exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 45.00
|
|
|
|
$ 45.00
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52,023
|
|
|
|
52,023
|
|
|
|
|
|
|
Series H-5 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
296,389
|
|
|
|
296,389
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.50
|
|
|
|
$ 2.50
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
5 years
|
|
|
|
|
|
|
Exercise of warrants, Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
173,091
|
|
|
|
|
|
|
Warrants description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per
share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting
in an adjusted exercise price per share from $3.96 to $2.50, resulting in an issuance of an additional 173,091 warrants that are exercisable
at $2.50 per share.
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
348,476
|
|
|
|
348,476
|
|
|
|
|
|
|
Deemed dividend |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 432,727
|
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
967,143
|
|
|
|
|
|
|
Fair value of modification of orinigal award |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 534,416
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
89.96%
|
|
|
|
|
|
|
Dividend yield |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.24%
|
|
|
|
|
|
|
Series I, H-1, H-3, H-4, J and H-5 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expire through the years 2022-2024
|
|
|
|
|
|
|
June Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,273
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.75
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
June Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
126,000
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.875
|
July 8 Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
71,770
|
|
|
|
71,770
|
|
|
|
|
71,770
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.225
|
|
July 8 Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
147,368
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.4625
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
July 22 Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
129,500
|
|
|
|
129,500
|
|
|
129,500
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.750
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
September Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
31,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 66,845
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
$ 3.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
31,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration description |
|
|
|
|
|
|
The September Warrant is
immediately exercisable and expires on September 25, 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease in exercise price |
|
|
|
|
|
|
$ 2.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
56,256
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
$ 6.6660
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56,256
|
|
|
|
56,256
|
|
|
|
|
|
|
November Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
57,756
|
|
|
|
|
|
|
|
|
57,756
|
|
|
|
57,756
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
$ 6.9690
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants description |
|
|
|
|
|
The
November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
15,574
|
|
|
|
|
|
|
|
|
|
|
51,459
|
|
|
|
51,459
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
$ 10.925
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
255,584
|
|
|
|
|
|
|
|
|
|
|
255,584
|
|
|
|
255,584
|
|
|
|
|
|
|
Warrants term |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series H-6 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
225,590
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued during conversion, shares |
|
|
|
|
|
|
|
|
|
|
|
7,833
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series H-3 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock stated value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 138
|
|
|
|
$ 138
|
|
|
|
|
|
|
Aggregate issued and outstanding shares percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.99%
|
|
|
|
9.99%
|
|
|
|
|
|
|
Series H Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock stated value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 154
|
|
|
|
$ 154
|
|
|
|
|
|
|
Preferred stock, conversion price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 184.80
|
|
|
|
|
|
|
Aggregate issued and outstanding shares percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.99%
|
|
|
|
9.99%
|
|
|
|
|
|
|
Series H-6 Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock stated value |
|
|
|
|
|
|
|
|
|
$ 72.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, conversion price |
|
|
|
|
|
|
|
|
|
$ 3.60
|
|
|
|
|
|
|
|
|
$ 3.60
|
|
|
|
|
|
|
Aggregate issued and outstanding shares percentage |
|
|
|
|
|
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, designated |
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, conversion price description |
|
|
|
|
|
|
|
|
|
Each share of Series H-6 Preferred Stock is convertible
at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6
Stated Value by the initial conversion price of $3.60 per share, which was then further reduced to $2.50 under the anti-dilution adjustment
provision, subject to a 9.99% blocker provision.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,074,645
|
|
|
|
|
Shares issued during conversion, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,007,193
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
5,092,806
|
|
|
|
|
|
5,092,806
|
|
|
|
5,092,806
|
|
|
|
|
Cash proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,926,818
|
|
|
|
|
Shares issued during conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 201
|
|
|
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 39
|
$ 7
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
394,589
|
74,987
|
|
|
|
|
|
|
|
|
|
Exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 183
|
|
|
|
|
|
|
|
Exercise of warrants, Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,831,733
|
|
|
|
|
|
|
|
Common Stock [Member] | February Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
35,885
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
$ 10.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | Series H-3 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
795
|
|
|
|
|
Shares issued during conversion, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
955
|
|
|
|
|
Preferred stock, conversion price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 165.60
|
|
|
|
|
|
|
AYRO Seed Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,007,193
|
|
|
|
|
Shares issued during conversion, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,360,985
|
|
|
|
|
Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
4,400,001
|
3,333,334
|
1,650,164
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock |
|
|
|
$ 41,800,008
|
$ 20,000,004
|
$ 10,000,000
|
|
$ 1,512,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering expenses |
|
|
|
$ 3,394,054
|
$ 1,648,608
|
847,619
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
$ 13,642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 469,576
|
|
|
|
|
|
|
Shares issued for exercised stock options |
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,224,917
|
|
|
|
|
|
|
Offering price |
|
|
|
|
$ 6.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
$ 6.93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant purchase price |
|
|
|
|
$ 233,334
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Series A Warrants and Series B [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of common stock issued |
|
|
|
|
|
$ 9,999,997
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Series A Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
1,237,624
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
$ 8.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Series B Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
825,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
$ 8.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | January 2021 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
3,333,334
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
$ 6.93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Additional Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
420,000
|
|
|
|
|
Common stock, par value |
|
|
|
$ 0.0001
|
0.0001
|
0.0001
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
|
|
|
|
Offering price |
|
|
|
$ 9.50
|
$ 6.00
|
$ 6.06
|
|
$ 5.00
|
|
|
5.00
|
|
|
|
|
|
5.00
|
|
|
|
$ 5.00
|
|
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,100,000
|
|
|
|
|
Offering expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
168,000
|
|
|
|
|
Purchase of additional shares description |
(i) sell up to 5% of such stockholder’s
holdings in the Company’s common stock on any trading day (with such 5% limitation to be measured as of the date of each sale)
and (ii) allow for unlimited sales of the Company’s common stock for any sales made at $10.00 per share or greater.
|
|
|
Each purchaser was also granted an option to purchase, on or before
February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial
closing, or an aggregate of 3,300,001 shares, at an exercise price of $11.50 per share.
|
|
|
|
Each purchaser also had the right to purchase, on or before October 19, 2020, additional shares of common stock (the “Additional
Shares”) equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 1,387,500
shares, at an offering price of $5.00 per share.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,817
|
|
|
|
|
Shares issued for exercised stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,669
|
|
|
|
|
Securities Purchase Agreement [Member] | Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
3,300,001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of stock sold |
|
|
|
|
|
|
|
1,850,000
|
3,157,895
|
|
|
|
|
2,200,000
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
Offering price |
|
|
|
|
|
|
|
$ 5.00
|
$ 4.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.50
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
|
$ 9,250,000
|
$ 15,000,000
|
|
|
|
|
$ 5,500,000
|
|
|
|
|
|
|
|
|
|
|
|
Offering expenses |
|
|
|
|
|
|
|
$ 740,000
|
$ 1,249,200
|
|
|
|
|
$ 435,000
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Investor [Member] | Additional Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price |
|
|
|
$ 11.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Purchase Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,573,218
|
|
|
|
|
Common stock, par value |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
|
|
|
|
Offering expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 609,010
|
|
|
|
|
Cash proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,000,000
|
|
|
|
|
Bridge Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
553,330
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of common stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
$ 600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Bridge Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued during conversion, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,030,585
|
|
|
|
|
Shares issued during conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|